(Allergan plc)

	AGN latest price $245.9913 (-8.66%) ($239.1097 - $266.8195) on Mon. Sep. 28, 2015.
	Trend Analysis and Forecast
Average Daily Percentage Swing	2.27% (three month average)
RSI	22
Latest Price	$245.9913(-8.66%)
Stocks Behave Similarly	Similar Stock List
Daily Trend	AGN declines -2.2% a day on average for past five trading days.
Weekly Trend	AGN declines -3% a week on average for past two weeks.
Market Behavior	Broad based sell-off for large cap. Value stock sell-off for small cap.
Correlated ETFs	Broad market will support AGN advance at 0% a week (0% probability)   XLV(53%)    IBB(52%)    XBI(46%)    ARKG(42%)    IWF(41%)
Factors Impacting AGN price	AGN will decline at least -1.135% in a week (0% probabilities).   VIXM(-29%)    TLT(-17%)    UUP(-8%)    SHY(-6%)    IGOV(-3%)
Relative Volatility	(options are extremely cheap)
Market Trend Strength	-1.135% (StdDev 2.27%)
Hourly BBV	0 ()
Intraday Trend	-7%

Resistance Level	$282.22
5 Day Moving Average	$270.02(-8.9%)
10 Day Moving Average	$278.03(-11.52%)
20 Day Moving Average	$282.22(-12.84%)
To recent high	-24.9%
To recent low	0%
Market Cap	$81.103b

Allergan Plc engages in the research, development, and manufacture of pharmaceutical products. It operates through the following business segments: US Specialized Therapeutics; US General Medicine, and International. The US Specialized Therapeutics segment includes sales and expenses relating to branded products within the United States. The US General Medicine segment involves Central Nervous System; Gastrointestinal; Women's Health; Anti-Infectives; and Diversified brands. The International segment comprises of products sold outside the United States. The company was founded in 1984 and is headquartered in Dublin, Ireland.

getNextHourMoveProbability failed